Net shares · 365d
-378.9K
0 buy · 378.9K sell
Net value · 365d
-$21.3M
$0 in · $21.3M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
18
0 buy · 378.9K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
XENE Sell·S
PRESIDENT & CEO · 10b5-1
$403.6K
7.3K sh · $55.23
Own -27%
-
XENE Exercise·M
PRESIDENT & CEO · 10b5-1
$0
12.5K sh
Own +50%
-
XENE Exercise·M
PRESIDENT & CEO · 10b5-1
—
12.5K sh
Own +85%
-
XENE Sell·S
PRESIDENT & CEO · 10b5-1
$17.0M
281.3K sh · $60.32 avg · 10 lots
Own -95%
-
XENE Exercise·M
PRESIDENT & CEO · 10b5-1
$0
290.0K sh · 5 lots
Own New
-
XENE Grant·A
PRESIDENT & CEO · 10b5-1
$0
20.0K sh
Own New
-
XENE Exercise·M
PRESIDENT & CEO · 10b5-1
$1.8M
290.0K sh · $6.28 avg · 5 lots
Own New
-
XENE Grant·A
PRESIDENT & CEO
$0
415.0K sh · 2 lots
Own New
-
XENE Exercise·M
PRESIDENT & CEO · 10b5-1
$0
40.0K sh
Own New
-
XENE Sell·S
PRESIDENT & CEO · 10b5-1
$1.8M
40.0K sh · $44.43 avg · 2 lots
Own -87%
-
XENE Exercise·M
PRESIDENT & CEO · 10b5-1
$299.6K
40.0K sh · $7.49
Own +667%
-
XENE Sell·S
PRESIDENT & CEO · 10b5-1
$1.1M
25.2K sh · $45.33 avg · 3 lots
Own -76%
-
XENE Sell·S
PRESIDENT & CEO · 10b5-1
$4.4K
97 sh · $45.01
Own -0%
-
XENE Exercise·M
PRESIDENT, CEO & INTERIM CFO · 10b5-1
$0
25.0K sh
Own New
-
XENE Exercise·M
PRESIDENT, CEO & INTERIM CFO · 10b5-1
$192.2K
25.0K sh · $7.69
Own +80%
-
XENE Sell·S
PRESIDENT, CEO & INTERIM CFO · 10b5-1
$1.0M
25.0K sh · $40.16
Own -44%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Mar 13, 2026 | XENE | Sell S | 7.3K | $403.6K |
| Mar 12, 2026 | XENE | Exercise M | 12.5K | $0 |
| Mar 12, 2026 | XENE | Exercise M | 12.5K | — |
| Mar 10, 2026 | XENE | Sell S | 281.3K10 lots | $17.0M |
| Mar 9, 2026 | XENE | Exercise M | 290.0K5 lots | $0 |
| Mar 9, 2026 | XENE | Grant A | 20.0K | $0 |
| Mar 9, 2026 | XENE | Exercise M | 290.0K5 lots | $1.8M |
| Jan 9, 2026 | XENE | Grant A | 415.0K2 lots | $0 |
| Jan 2, 2026 | XENE | Exercise M | 40.0K | $0 |
| Jan 2, 2026 | XENE | Sell S | 40.0K2 lots | $1.8M |
| Jan 2, 2026 | XENE | Exercise M | 40.0K | $299.6K |
| Dec 8, 2025 | XENE | Sell S | 25.2K3 lots | $1.1M |
| Nov 28, 2025 | XENE | Sell S | 97 | $4.4K |
| Oct 1, 2025 | XENE | Exercise M | 25.0K | $0 |
| Oct 1, 2025 | XENE | Exercise M | 25.0K | $192.2K |
| Oct 1, 2025 | XENE | Sell S | 25.0K | $1.0M |
Buy Sell Non-market (grant · exercise · gift)
About MORTIMER IAN
This profile aggregates every SEC Form 4 insider transaction reported by MORTIMER IAN across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.